03/31/2025
3:45 PM | Aardvark Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
4:55 PM | Aardvark Therapeutics (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SCHEDULE 13G | |
02/24/2025
6:00 AM | Aardvark Therapeutics (Subject)
Tan Finian (Filed by)
| Form SCHEDULE 13G | |
02/19/2025
4:44 PM | Aardvark Therapeutics (Issuer)
Cui Xiangmin (Reporting)
Decheng Capital Global Healthcare Fund , LP (0001949026) (Reporting)
Decheng Capital Global Healthcare GP, LLC (Reporting)
Decheng Capital Global Life Sciences Fund IV, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:57 PM | Aardvark Therapeutics (Issuer)
Chi Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:48 PM | Aardvark Therapeutics (Issuer)
Vickers Venture Fund VI Pte Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:30 PM | Aardvark Therapeutics (Issuer)
Sun Nelson (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:02 PM | Aardvark Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/12/2025
11:15 PM | Aardvark Therapeutics (Filer)
| Form EFFECT | |
02/12/2025
6:47 PM | Aardvark Therapeutics (Issuer)
Cui Xiangmin (Reporting)
Decheng Capital Global Healthcare Fund , LP (0001949026) (Reporting)
Decheng Capital Global Healthcare GP, LLC (Reporting)
Decheng Capital Global Life Sciences Fund IV, L.P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:32 PM | Aardvark Therapeutics (Issuer)
Tong Victor Edward Jr (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:07 PM | Aardvark Therapeutics (Issuer)
Jaiman Manasi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:11 PM | Aardvark Therapeutics (Issuer)
Vickers Venture Fund VI Pte Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:17 PM | Aardvark Therapeutics (Issuer)
Graf Susan E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:19 PM | Aardvark Therapeutics (Issuer)
Baynes Roy D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:24 PM | Aardvark Therapeutics (Issuer)
Sun Nelson (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:24 PM | Aardvark Therapeutics (Issuer)
Jones Bryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
5:49 PM | Aardvark Therapeutics (Issuer)
Lee Tien-Li (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
5:55 PM | Aardvark Therapeutics (Issuer)
Chi Jeffrey (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
4:18 PM | Aardvark Therapeutics (Issuer)
Chen Bihua (Reporting)
Cormorant Asset Management, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
1:05 PM | Aardvark Therapeutics (Filer)
| Form CERT | |
02/06/2025
3:02 PM | Aardvark Therapeutics (Filer)
| Form S-1/A | |
01/23/2025
3:57 PM | Aardvark Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/15/2024
1:36 PM | Aardvark Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
